HUP0102815A3 - New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it - Google Patents

New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it

Info

Publication number
HUP0102815A3
HUP0102815A3 HU0102815A HUP0102815A HUP0102815A3 HU P0102815 A3 HUP0102815 A3 HU P0102815A3 HU 0102815 A HU0102815 A HU 0102815A HU P0102815 A HUP0102815 A HU P0102815A HU P0102815 A3 HUP0102815 A3 HU P0102815A3
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical compositions
crystalline form
compositions containing
butylamine salt
Prior art date
Application number
HU0102815A
Other languages
Hungarian (hu)
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0008793A external-priority patent/FR2811320B1/en
Application filed by Servier Lab filed Critical Servier Lab
Priority to HU0102815A priority Critical patent/HU225340B1/en
Publication of HU0102815D0 publication Critical patent/HU0102815D0/en
Publication of HUP0102815A2 publication Critical patent/HUP0102815A2/en
Publication of HUP0102815A3 publication Critical patent/HUP0102815A3/en
Publication of HU225340B1 publication Critical patent/HU225340B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
HU0102815A 2000-07-06 2001-07-05 New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it HU225340B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU0102815A HU225340B1 (en) 2000-07-06 2001-07-05 New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008793A FR2811320B1 (en) 2000-07-06 2000-07-06 NOVEL ALPHA CRYSTALLINE FORM OF TERT-BUTYLAMINE SALT OF PERINDOPRIL, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HU0102815A HU225340B1 (en) 2000-07-06 2001-07-05 New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it

Publications (4)

Publication Number Publication Date
HU0102815D0 HU0102815D0 (en) 2001-09-28
HUP0102815A2 HUP0102815A2 (en) 2002-02-28
HUP0102815A3 true HUP0102815A3 (en) 2003-12-29
HU225340B1 HU225340B1 (en) 2006-09-28

Family

ID=89979493

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102815A HU225340B1 (en) 2000-07-06 2001-07-05 New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it

Country Status (1)

Country Link
HU (1) HU225340B1 (en)

Also Published As

Publication number Publication date
HUP0102815A2 (en) 2002-02-28
HU225340B1 (en) 2006-09-28
HU0102815D0 (en) 2001-09-28

Similar Documents

Publication Publication Date Title
HU0102814D0 (en) New gamma crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it
HU0102813D0 (en) New betha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it
HUP0301351A3 (en) Use of substituted dipeptides as growth hormone secretagogues, process for their preparation and pharmaceutical compositions containing them
AU2001276419A1 (en) Novel beta crystalline form of perindopril tert- butylamine salt, preparation method and pharmaceutical compositions containing same
AU2001276420A1 (en) Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
AU7641801A (en) Alpha crystalline form of perindopril tert-butylamine salt
HUP0302519A3 (en) Crystalline forms of atorvastatin, process for their preparation and pharmaceutical compositions containing them
HUP0400927A3 (en) New crystalline form and pure modafinil, process of preparing them, and pharmaceutical compositions containing the new crystalline form
HUP0200190A3 (en) Dimeric compounds and as inhibitors of neuraminidase, process for their preparation and pharmaceutical compositions containing them
HUP0300148A3 (en) Dipeptide nitrile cathepsin k inhibitors, process for their preparation and pharmaceutical compositions containing them
PL396568A1 (en) Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate
HUP0401141A3 (en) Crystalline forms of fluvastatin sodium, process for their preparation and pharmaceutical compositions containing them
HUP0201909A3 (en) Aminobenzophenones as inhibitors of il-1betha and tnf-alpha, process for producing them and pharmaceutical compositions containing them
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0401499A3 (en) Indole derivatives as cox ii inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0402391A3 (en) Crystalline sodium salt of telmisartan, process for its production and pharmaceutical compositions containing it
HUP0300389A3 (en) Crystalline form ii of cabergoline, process for its preparation and pharmaceutical compositions containing it
HUP0300231A3 (en) Process for the preparation of high purity perindopril and intermediates useful in the synthesis, pharmaceutical compositions containing the compound and their use
HUP0204005A3 (en) Novel forms of pravastatin sodium, process for their preparation and pharmaceutical compositions containing them
HUP0200913A3 (en) Isoindoindololone derivatives process for their preparation and pharmaceutical compositions containing them
HU0102815D0 (en) New alpha crystalline form of perindopril tert-butylamine salt, process for its preparation and pharmaceutical compositions containing it
HUP0402283A3 (en) Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine, process for their preparation and pharmaceutical compositions containing them
HUP0401912A3 (en) Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them
SI1266887T1 (en) Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
HU1000441D0 (en) Substituted alkylpyridazone derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: LES LABORATOIRES SERVIER, FR

Free format text: FORMER OWNER(S): ADIR ET COMPAGNIE, FR

MH4A Lapse of definitive patent protection due to relinquishment
MC4A Revocation of the patent